Workflow
YAXING CHEMICAL(600319)
icon
Search documents
亚星化学(600319) - 2022 Q2 - 季度财报
2022-08-09 16:00
Financial Performance - The company's operating revenue for the first half of 2022 reached RMB 401,900,980.48, a significant increase of 1,556.26% compared to RMB 24,265,545.78 in the same period last year[18]. - The net profit attributable to shareholders was RMB 29,842,477.26, recovering from a loss of RMB 12,148,903.23 in the previous year[18]. - Basic earnings per share for the first half of 2022 were RMB 0.09, compared to a loss of RMB -0.04 in the same period last year[19]. - The company reported a net loss of CNY 957,363,553.82, compared to a loss of CNY 987,206,031.08 in the previous period, showing an improvement of approximately 3.0%[82]. - The total comprehensive income for the period was CNY -12,859,259.36, indicating a loss compared to the previous period[98]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at RMB -71,160,152.53, slightly improved from RMB -77,810,269.47 in the same period last year[18]. - The net cash flow from investment activities was ¥116,156,486.14, a substantial improvement from -¥60,030,966.91 in the previous year[35]. - The total cash and cash equivalents at the end of the period stood at 11,403,705.50 RMB, down from 38,998,786.18 RMB at the end of the first half of 2021[92]. - The company's cash and cash equivalents at the end of the period totaled CNY 26,109,693.45, a decrease from CNY 86,980,239.66 at the beginning of the period[196]. Assets and Liabilities - The company's total assets increased by 4.63% to RMB 1,864,352,557.08 compared to RMB 1,781,859,933.62 at the end of the previous year[18]. - Total liabilities increased to CNY 1,602,674,771.67, up from CNY 1,550,024,625.47, reflecting a growth of approximately 3.3%[82]. - Current liabilities totaled CNY 1,375,489,538.38, a decrease of about 4.6% from CNY 1,442,551,810.22[82]. - Non-current liabilities rose significantly to CNY 227,185,233.29, compared to CNY 107,472,815.25, marking an increase of approximately 111.1%[82]. Production and Operations - The company successfully launched a 120,000-ton/year caustic soda facility in April 2022, achieving full production capacity[20]. - The construction of the 150,000 tons/year hydrogen peroxide project is underway, with 40% of the civil engineering completed by the end of June 2022[29]. - The first set of 50,000 tons/year CPE and 120,000 tons/year ion membrane caustic soda projects have been completed and are operational[29]. - The company is currently in the process of recovering production capacity following the relocation of its manufacturing facilities, which may impact future performance[7]. Environmental Compliance - The wastewater discharge concentration for ammonia nitrogen was 0.338 mg/L, with a total discharge of 0.0487 tons from January to June, meeting standards[49]. - The chemical oxygen demand (COD) concentration was 18.5 mg/L, with a total discharge of 2.95 tons from January to June, also meeting standards[49]. - The company has established a self-monitoring plan for environmental compliance, including wastewater, waste gas, soil, groundwater, and noise monitoring, with online monitoring systems operating normally[54]. - There were no administrative penalties for environmental issues during the reporting period[55]. Financing and Shareholder Information - The company raised a total of RMB 299,999,997.44 through a non-public offering of 72,115,384 shares at a price of RMB 4.16 per share[20]. - The company has a total of 63,832,797 shares controlled by the controlling shareholder, accounting for 20.22% of the total share capital[75]. - The company has fully repaid all loans applied for from Weifang City Investment Group as of the report release date[62]. Regulatory and Compliance Issues - The company received a regulatory warning from the Shanghai Stock Exchange due to inaccuracies in financial disclosures, emphasizing the need for improved compliance and internal management[59]. - The financial report for the first half of 2022 was approved by the board of directors on August 9, 2022[104]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring that the financial statements reflect a true and complete picture of its financial status and performance[109][110]. Research and Development - Research and development expenses for the first half of 2022 amounted to ¥3,297,434.85, compared to ¥2,168,088.11 in the first half of 2021, indicating a focus on innovation and development[86]. Accounting Policies - The company has not made any changes to significant accounting policies or estimates during the reporting period[194]. - The company uses the expected credit loss model to assess the impairment of financial instruments, considering historical repayment data and macroeconomic indicators[190].
亚星化学(600319) - 2021 Q4 - 年度财报
2022-05-08 16:00
Financial Performance - In 2021, the company's operating revenue reached approximately CNY 192.70 million, a significant increase of 290.93% compared to CNY 49.29 million in 2020[21]. - The net profit attributable to shareholders of the listed company was approximately CNY 193.03 million, recovering from a loss of CNY 25.67 million in 2020[21]. - The company's total assets at the end of 2021 were approximately CNY 1.78 billion, a slight decrease of 1.51% from CNY 1.81 billion in 2020[22]. - The net assets attributable to shareholders of the listed company increased to approximately CNY 231.84 million, a substantial increase of 497.05% from CNY 38.83 million in 2020[22]. - The basic earnings per share for 2021 was CNY 0.61, compared to a loss of CNY 0.08 per share in 2020[23]. - The weighted average return on net assets was 142.62% in 2021, a significant recovery from -49.62% in 2020[23]. - The company achieved operating revenue of 192.7 million RMB in 2021, an increase of 143.41 million RMB year-on-year, indicating a recovery growth trend[33]. - The net profit attributable to shareholders of the listed company for 2021 was 193 million RMB, after deducting operational losses[33]. - The company reported a significant increase in non-operating income, including government subsidies related to the relocation[28]. - The company reported a net profit attributable to shareholders significantly boosted by government compensation related to the demolition of old facilities[44]. Production and Operations - The company has resumed production and sales of CPE (Chlorinated Polyethylene) in 2021 after a halt in production since late 2019[23]. - The first phase of the 50,000 tons/year CPE project was completed and put into operation in June 2021, leading to a substantial increase in sales volume in the third and fourth quarters[26]. - The company completed the construction and operation of a 50,000 tons/year CPE facility and a 120,000 tons/year ion membrane caustic soda facility, which is ready for production[39]. - The production of CPE reached 23,998 tons, with sales volume at 22,190.60 tons, including 2,317.25 tons from trial production[48]. - The company has resumed production with a focus on high-demand product lines, ensuring continuous supply to key customers, while adjusting its sales model to increase the proportion of distribution sales temporarily[68]. Research and Development - The company’s R&D expenses rose by 128.20% to CNY 5.15 million, reflecting a focus on innovation[43]. - The total R&D investment for the period was 5,150,159.06, representing 2.67% of operating revenue[55]. - The company has 55 R&D personnel, making up 6.52% of the total workforce[56]. - The company is committed to R&D for new product categories and applications in CPE, aiming for strategic transformation and upgrades[89]. - The company has initiated feasibility studies and early development for new products, including magnesium series chemicals and conductive polymer materials, leveraging local resources[70]. Financial Management - The company’s financial expenses increased by approximately CNY 20 million due to new related party borrowings and changes in accounting for financial costs during the relocation period[42]. - The net cash flow from financing activities was CNY 187.87 million, a decrease of 76.49% compared to the previous period[44]. - The company received a total of 1.051 billion RMB in relocation compensation funds, which significantly increased the annual net profit and year-end net asset value[33]. - The company proposed a non-public offering of A-shares to raise up to 300 million RMB for working capital, with the plan already accepted by the China Securities Regulatory Commission[34]. - The company received a bank loan of 23.5 million while repaying 1.25 million in due loans during the reporting period[60]. Governance and Compliance - The company held 4 shareholder meetings, 11 board meetings, and 5 supervisory board meetings during the reporting period, ensuring compliance with regulations and equal rights for all shareholders[93]. - The company maintained independent operations, with no interference from the controlling shareholder or actual controller in business decisions[94]. - The company’s governance structure complies with relevant laws and regulations, ensuring operational independence from its controlling shareholder[97]. - The company received a disciplinary notice from the Shanghai Stock Exchange for incomplete information disclosure regarding a major asset restructuring, leading to significant stock price fluctuations[116]. - The company plans to strictly adhere to legal and regulatory requirements for information disclosure in the future[117]. Environmental and Social Responsibility - The company has established a self-monitoring plan for environmental compliance, including regular monitoring of wastewater, air emissions, soil, groundwater, and noise[143]. - The company has made significant investments in environmental protection measures, including the installation of dust suppression systems at construction sites[137]. - The company emphasizes employee rights and welfare, providing a comprehensive compensation and benefits system to support staff development[147]. - The company has developed emergency response plans for environmental incidents related to production shutdowns and relocations[142]. - The company faced an administrative penalty of 550,000 yuan due to exceeding particulate matter emission standards, which has since been rectified[145]. Future Outlook - The company provided a performance guidance for 2022, expecting revenue to grow by 20% to reach approximately 1.8 billion[103]. - New product launches are anticipated to contribute an additional 300 million in revenue in 2022[103]. - The company plans to implement a second phase project for an additional 50,000 tons/year CPE facility and a 150,000 tons/year hydrogen peroxide project, with construction already underway[74]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 200 million allocated for potential deals[103]. - The company aims to complete the construction of a 150,000 tons/year hydrogen peroxide project and a second 50,000 tons/year CPE facility to restore profitability in 2022[88].
亚星化学(600319) - 2022 Q1 - 季度财报
2022-04-29 16:00
2022 年第一季度报告 证券代码:600319 证券简称:*ST 亚星 潍坊亚星化学股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务报表 信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位:元 币种:人民币 | 项目 | 本报告期 | 本报告期比上年同期增减 | | --- | --- | --- | | | | 变动幅度(%) | | 营业收入 | 154,542,852.91 | 191,312.33 | | 归属于上市公司股东的净利润 | -3,780,195.06 | 不适用 | | 归属于上市公司股东的扣除非经常 | -4,326,071.64 | 不适用 | ...
亚星化学(600319) - 2021 Q4 - 年度财报
2022-03-04 16:00
Financial Performance - The company's operating revenue for 2021 was approximately ¥192.70 million, representing a 290.93% increase compared to ¥49.29 million in 2020[21]. - The net profit attributable to shareholders for 2021 was approximately ¥193.03 million, a significant recovery from a loss of ¥25.67 million in 2020[21]. - The net profit after deducting non-recurring gains and losses was approximately -¥72.34 million, worsening from -¥37.91 million in 2020[21]. - The total assets at the end of 2021 were approximately ¥1.87 billion, a decrease of 3.94% from ¥1.94 billion at the end of 2020[21]. - The net assets attributable to shareholders increased by 497.05% to approximately ¥231.84 million from ¥38.83 million in 2020[21]. - The cash flow from operating activities for 2021 was approximately -¥83.54 million, compared to -¥35.54 million in 2020[21]. - The basic earnings per share for 2021 was 0.61 RMB, a recovery from a loss of 0.08 RMB in 2020[22]. - The company reported a net loss of CNY 987,206,031.08 in 2021, an improvement from a net loss of CNY 1,180,231,950.44 in 2020, indicating a reduction in losses of about 16.4%[182]. - The total comprehensive income for 2021 was ¥214,836,327.22, compared to a loss of ¥23,327,182.91 in 2020[188]. Operational Developments - The company completed the construction and commissioning of a 50,000 tons/year CPE production facility in 2021, marking the resumption of production after relocation[30]. - The company plans to implement a second 50,000 tons/year CPE production facility and a 150,000 tons/year hydrogen peroxide project, with necessary approvals already obtained[30]. - The production of CPE started in June 2021, with a total production volume of 23,998 tons and sales volume of 22,190.60 tons, including 2,317.25 tons from trial production[47]. - The company has restored an annual production capacity of 50,000 tons for chlorinated polyethylene (CPE) and is prioritizing high-demand product markets while ensuring continuous supply to key customers[61]. - The company’s CPE production facility has been completed and is operational, enhancing its competitive position in the high-end product market[60]. Strategic Initiatives - The company is focusing on sustainable development and resource-saving practices as part of its new circular economy strategy[36]. - The company is considering strategic acquisitions to bolster its product portfolio, with a budget of 100 million allocated for potential deals[100]. - The company is investing 50 million in R&D for new technologies aimed at enhancing product efficiency[100]. - The company has initiated feasibility studies and preliminary development for new product categories, including magnesium series chemicals and conductive polymer materials[64]. - The company plans to complete the construction of a 150,000 tons/year hydrogen peroxide project and a second 50,000 tons/year CPE facility to restore profitability[81]. Governance and Compliance - The company has established a risk management framework to address potential delays in project completion and funding challenges[83]. - The independent directors actively fulfill their duties and provide objective opinions on board matters, ensuring the protection of all shareholders' rights[88]. - The company has established a performance evaluation and incentive mechanism for senior management, ensuring accountability[90]. - The company is committed to improving its operational compliance and enhancing investor communication following the disciplinary actions[109]. - The company has successfully completed the restructuring of its board and supervisory board, enhancing governance[88]. Shareholder and Capital Management - The company plans to issue A-shares to its controlling shareholder, raising up to 300 million RMB to supplement working capital[32]. - The company proposed a non-public stock issuance to raise funds, with a feasibility analysis report included[94]. - The total remuneration for directors and senior management during the reporting period amounted to 3.88 million yuan[96]. - The company has outlined a three-year dividend return plan from 2021 to 2023[94]. - The company’s major shareholder, Weifang City Investment Group, now holds 21.20% of the voting rights following a voting rights delegation agreement[86]. Environmental and Social Responsibility - The company has completed environmental impact assessments for its projects, including a 50,000 tons/year CPE facility and a 120,000 tons/year ion-exchange membrane caustic soda project[128]. - The company faced an administrative penalty of 550,000 yuan due to exceeding particulate matter emission standards, which was rectified promptly[134]. - The company has established a self-monitoring plan for environmental protection, including regular monitoring of wastewater, air emissions, soil, groundwater, and noise[132]. - The company has made significant investments in employee welfare, including regular health check-ups and a comprehensive compensation system[136]. - Overall, the company remains committed to sustainable practices, aiming for a 20% reduction in carbon emissions by 2025[100].
亚星化学(600319) - 潍坊亚星化学股份有限公司关于参加山东辖区上市公司2021年度投资者网上集体接待日活动的公告
2021-11-12 07:44
Group 1: Event Details - The company will participate in the "2021 Annual Investor Online Collective Reception Day" organized by the Shandong Securities Regulatory Bureau and the Shandong Listed Companies Association [1] - The online event will be held on November 16, 2021, from 14:00 to 16:00 [1] - Investors can access the event through the "Panjing Roadshow" website [1] Group 2: Company Representatives - The company's Chief Financial Officer, Mr. Lun Xiuhua, will be present for the online communication [1] - Other representatives include board members and the board secretary, Mr. Li Wenqing, and securities affairs representative, Mr. Su Xin [1] Group 3: Investor Engagement - The company encourages active participation from investors during the online interaction [1] - The initiative aims to strengthen communication and build harmonious investor relations [1]
亚星化学(600319) - 2021 Q3 - 季度财报
2021-10-29 16:00
Financial Performance - The company's operating revenue for Q3 2021 was ¥73,143,223.54, representing an increase of 1,685.42% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥22,568,459.12, with a year-to-date net profit of -¥34,717,362.35, indicating a significant loss[5]. - The basic and diluted earnings per share were both -¥0.07, reflecting a decrease from -¥0.11 in the previous year[6]. - Total operating revenue for the first three quarters of 2021 reached ¥97,408,769.32, a significant increase from ¥42,842,047.28 in the same period of 2020, representing a growth of approximately 127.5%[25]. - The net loss for the first three quarters of 2021 was ¥34,717,362.35, worsening from a net loss of ¥19,979,155.37 in the same period of 2020[25]. - The total comprehensive income attributable to the parent company was -34,717,362.35 CNY, compared to -19,979,155.37 CNY in the same period last year, indicating a decline[26]. Assets and Liabilities - Total assets increased by 24.15% to ¥2,411,161,815.04 compared to the end of the previous year[6]. - The company's total assets as of September 30, 2021, amounted to ¥2,411,161,815.04, up from ¥1,942,131,835.39 at the end of 2020, reflecting an increase of approximately 24.2%[22]. - Current assets totaled ¥383,771,130.99 as of September 30, 2021, compared to ¥113,604,541.40 at the end of 2020, marking a substantial increase of about 237.5%[20]. - The total liabilities as of September 30, 2021, were ¥2,407,048,788.60, compared to ¥1,903,301,446.60 at the end of 2020, representing an increase of approximately 26.4%[22]. - Long-term borrowings increased to ¥27,250,000.00 in 2021 from ¥5,000,000.00 in 2020, reflecting a rise of 445%[22]. Cash Flow - Cash flow from operating activities was -¥60,410,662.82 year-to-date, indicating negative cash flow[6]. - The net cash flow from operating activities was -60,410,662.82 CNY, an improvement from -70,270,474.18 CNY year-over-year[28]. - Cash received from sales of goods and services increased to 91,446,684.58 CNY, up from 67,538,467.27 CNY in the previous year, reflecting a growth of approximately 35.4%[27]. - The net cash flow from investing activities was -19,041,620.49 CNY, a decrease from 12,047,706.42 CNY in the same period last year[28]. - Cash inflow from financing activities was 1,090,950,000.00 CNY, significantly higher than 351,542,500.00 CNY in the previous year[28]. - The company received 784,500,000.00 CNY in borrowings, up from 351,542,500.00 CNY in the previous year, indicating increased leverage[28]. Research and Development - The company reported a 201.22% increase in R&D expenses, attributed to higher personnel costs[11]. - The company reported a significant increase in research and development expenses, which rose to ¥3,635,851.48 in the first three quarters of 2021 from ¥1,207,039.02 in 2020, an increase of about 201.5%[25]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,202[13]. - The largest shareholder, Weifang Urban Construction Development Investment Group, holds 40,000,000 shares, accounting for 12.6% of total shares[14]. - The second largest shareholder, Weifang Yaxing Group, holds 26,932,729 shares, representing 8.53% of total shares[14]. - The total shares held by the four shareholders associated with Weifang Yuyue Enterprise Management Co., Ltd. amount to 41,653,962 shares, or 13.2% of total shares, making them the second largest shareholder[16]. - The company has a total of 30,077,029 shares controlled by the partners of eleven shareholders, representing 9.52% of total shares, making them the third largest shareholder[16]. - The company has several shareholders with pledged shares, including Shenzhen Zhong'an Huiyin No. 1 Special Investment Enterprise, which has 12,737,632 shares pledged[13]. - The company is actively managing its shareholder structure, with no reported related party transactions among other shareholders[16]. Production and Expansion - The company plans to continue expanding its CPE production capacity and exploring new market opportunities[11]. - The company has established a new plant in Changyi City, covering approximately 1,092 acres, with ongoing construction of a 50,000 tons/year CPE facility and a 120,000 tons/year ion membrane caustic soda facility[17]. - The company is in the process of relocating equipment from the old plant, which has been fully shut down since October 31, 2019[17]. - The company’s gross profit margin improved due to the commencement of CPE production in June 2021, leading to increased sales revenue[11]. Accounting and Compliance - The company is adhering to accounting standards for the accurate processing of fixed asset revaluation as it relocates and dismantles old facilities[18].
亚星化学(600319) - 2021 Q2 - 季度财报
2021-08-30 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was ¥24,265,545.78, a decrease of 37.37% compared to ¥38,745,341.66 in the same period last year[17]. - The net profit attributable to shareholders was -¥12,148,903.23, an improvement from -¥16,906,201.89 in the previous year[17]. - The net cash flow from operating activities was -¥77,810,269.47, compared to -¥48,199,284.60 in the same period last year[17]. - The basic earnings per share for the first half of 2021 was -¥0.04, compared to -¥0.05 in the same period last year[18]. - The weighted average return on net assets was -37.09%, down from -30.12% in the previous year[18]. - The company reported a net cash flow from operating activities of -RMB 35.54 million for the reporting period, indicating financial challenges[61]. - The company reported a total comprehensive loss of CNY 4,701,969.79 for the first half of 2021[110]. Assets and Liabilities - The total assets increased by 18.04% to ¥2,292,437,165.17 from ¥1,942,131,835.39 at the end of the previous year[17]. - The net assets attributable to shareholders decreased by 29.62% to ¥27,329,870.21 from ¥38,830,388.79 at the end of the previous year[17]. - Current liabilities rose to CNY 1,529,261,463.08, up from CNY 1,200,099,547.04, indicating an increase of about 27.5%[91]. - The company's total liabilities reached CNY 2,265,107,294.96, compared to CNY 1,903,301,446.60, marking an increase of approximately 19.1%[91]. - The company's retained earnings show a decline, with a balance of CNY -1,103,862,946.71 at the end of the reporting period, compared to CNY -1,099,160,976.92 at the beginning[110]. Production and Operations - The company has been in the process of relocating its production facilities since October 31, 2019, which has impacted the financial data for the reporting period[6]. - The new 50,000 tons/year CPE production facility was completed in the first half of 2021, but low production levels resulted in reduced sales revenue and low gross profit[18]. - The company is in the process of constructing a 120,000 tons/year ion membrane caustic soda facility, expected to complete equipment installation in the second half of 2021[25]. - The company aims to ensure the normal operation of the 50,000 tons/year CPE facility in the second half of 2021 to quickly capture market share and increase sales revenue[40]. - The company is gradually restoring production capacity, with most of the recovery still in progress[24]. Financing and Investments - The company plans to issue A-shares to raise up to 300 million RMB to supplement working capital, with the proposal already accepted by the China Securities Regulatory Commission[27]. - The company secured a new loan of ¥185 million from Weifang City Investment Group during the reporting period[34]. - The company reported a net cash outflow from investment activities of -¥60,030,966.91, a decline of 131.91% compared to a positive cash flow of ¥188,139,749.48 in the previous year[32]. - Cash flow from financing activities generated a net inflow of CNY 205,016,654.27, reversing from a net outflow of CNY -52,460,591.65 in the previous year[101]. Environmental Compliance - The company has implemented environmental monitoring systems, with wastewater discharge from Yaxing Chemical showing zero emissions for ammonia nitrogen and chemical oxygen demand[49]. - The environmental impact assessments for the 50,000 tons/year CPE project and the 120,000 tons/year ion-exchange membrane caustic soda project have been approved, with the CPE project currently undergoing environmental acceptance[52]. - The company was fined RMB 550,000 for exceeding emission standards as per the administrative penalty decision issued by the Weifang Ecological Environment Bureau[56]. Corporate Governance - The company held its first extraordinary shareholders' meeting of 2021 on March 3, 2021, and the resolutions were published on March 4, 2021[42]. - The company appointed a new management team, including a new chairman and several directors, effective from January 10, 2021[43]. - The company received a public reprimand from the Shanghai Stock Exchange for incomplete disclosure regarding a major asset restructuring, which affected investor rights and expectations[68]. - The company has committed to improving compliance and information disclosure practices following the reprimand, ensuring timely and accurate communication with investors[69]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,936[80]. - The largest shareholder, Weifang Urban Construction Development Investment Group Co., Ltd., held 40,000,000 shares, representing 12.67% of total shares[82]. - The second-largest shareholder, Weifang Yaxing Group Co., Ltd., held 26,932,729 shares, accounting for 8.53% of total shares[82]. - The company did not experience any changes in its share capital structure during the reporting period[79]. Research and Development - Research and development expenses increased significantly by 153.17% to ¥2,168,088.11, up from ¥856,384.45 in the previous year[32]. - The company reported a significant increase in research and development expenses to CNY 2,168,088.11, up from CNY 856,384.45, reflecting a focus on innovation[97]. Risk Management - There were no significant risk events reported during the reporting period[5]. - The company faces risks related to the timely completion of the new plant project and the demolition of the old plant, which could impact financial settlements and land recovery[38]. - The company is actively advancing the construction of the new plant and the demolition of the old plant, while also planning a non-public offering to mitigate related risks[40].
亚星化学(600319) - 2020 Q4 - 年度财报
2021-04-28 16:00
Financial Performance - In 2020, the company's operating revenue was CNY 49.29 million, a decrease of 97.02% compared to CNY 1.66 billion in 2019[23]. - The net profit attributable to shareholders was a loss of CNY 25.67 million, representing a decline of 187.88% from a profit of CNY 29.22 million in 2019[23]. - The net cash flow from operating activities was a negative CNY 35.54 million, down 118.91% from CNY 188.00 million in 2019[23]. - Basic earnings per share were -CNY 0.08, a decrease of 188.89% from CNY 0.09 in 2019[24]. - The weighted average return on net assets was -49.62%, a decrease of 106.48 percentage points from 56.86% in 2019[25]. - The company reported a cumulative loss of 1.18 billion RMB and a net cash flow from operating activities of -35.54 million RMB for the year 2020[96]. - The total comprehensive income for 2020 was a loss of RMB 25,752,518.32, compared to a total comprehensive income of RMB 29,191,010.90 in 2019[186]. - The company reported a significant increase in credit impairment losses of RMB 8,264,085.38 in 2020, compared to a gain of RMB 10,825,447.42 in 2019[185]. Assets and Liabilities - The total assets increased by 49.26% to CNY 1.94 billion at the end of 2020, compared to CNY 1.30 billion at the end of 2019[23]. - The company's net assets attributable to shareholders decreased by 39.88% to CNY 38.83 million at the end of 2020, down from CNY 64.58 million at the end of 2019[23]. - As of December 31, 2020, the company's current liabilities exceeded current assets by CNY 1,086.50 million, indicating significant liquidity concerns[168]. - The company's total liabilities reached CNY 1,903,301,446.60, compared to CNY 1,236,548,793.69 in 2019, reflecting a growth of around 54%[178]. - Owner's equity decreased to CNY 38,830,388.79 from CNY 64,582,907.11, a decline of approximately 39.9%[178]. Production and Operations - The company is currently in a shutdown and relocation phase, which has significantly impacted its financial performance[23]. - The company remained in a state of production halt throughout 2020, relying solely on sales of existing inventory[54]. - The company is in the process of relocating its production facilities, with new projects including a 50,000 tons/year CPE facility and a 120,000 tons/year ion-exchange membrane caustic soda facility under construction[35]. - The construction of the new plant is progressing, with the 50,000 tons/year CPE facility completed and in testing phase[66]. - The company has fully suspended production and is in the process of relocation since October 31, 2019, with ongoing construction of new facilities for 50,000 tons/year CPE, 120,000 tons/year caustic soda, and 12,000 tons/year hydrazine[75]. Market Conditions - The CPE market faced slow demand recovery in 2020, with prices declining in the first half and a significant increase in liquid chlorine prices in the second half[35]. - The caustic soda market remained oversupplied, leading to intense competition, but prices for by-product liquid chlorine increased, providing some profit stability[35]. - The hydrazine hydrate market saw slow demand recovery due to the pandemic, with prices remaining low until late 2020 when some companies limited production, leading to a price increase[36]. Corporate Governance - The company has a sound corporate governance structure, complying with relevant laws and regulations[154]. - Independent directors have actively participated in meetings and provided independent opinions on significant matters, ensuring the protection of minority shareholders' rights[161]. - The company has implemented measures to reduce and standardize related party transactions, with a significant decrease in transaction amounts due to the suspension of operations[157]. Future Plans and Investments - The company plans to invest in a new 50,000 tons/year CPE unit and a 150,000 tons/year hydrogen utilization project, pending shareholder approval[42]. - The company plans to implement a second 50,000 tons/year CPE facility and a 150,000 tons/year hydrogen utilization project in the new plant[66]. - In 2021, the company aims to ensure the 50,000 tons/year CPE unit starts operation and stabilizes production to quickly capture market share and increase sales revenue[91]. - The company plans to issue A-shares to raise up to 300 million RMB to supplement working capital and alleviate financial pressure[98]. Environmental and Safety Management - The company has established a comprehensive wastewater collection system, ensuring that wastewater is treated and meets standards before being discharged into the Yuhe sewage treatment plant[114]. - The company has implemented a self-monitoring plan for environmental emissions, including wastewater and noise, with real-time data displayed at the factory entrance[119]. - Safety and environmental management will be prioritized, with comprehensive training and responsibility agreements established to prevent accidents during construction and operation[86]. Employee and Shareholder Relations - The company has maintained its commitment to employee welfare, providing a comprehensive salary and benefits system to ensure employee rights[118]. - The number of ordinary shareholders increased from 11,821 to 12,111 during the reporting period[123]. - Total remuneration for all directors, supervisors, and senior management reached CNY 4.4985 million[143]. Legal and Compliance Issues - The company is facing significant litigation, including a case where it is required to pay RMB 2,656,684.44 for unfulfilled energy-saving payments[105]. - The company has faced regulatory penalties for inaccurate disclosures in the past, leading to improved compliance measures[145][146].
亚星化学(600319) - 2021 Q1 - 季度财报
2021-04-28 16:00
| 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 7 | | 四、 | 附录 9 | 2021 年第一季度报告 2021 年第一季度报告 公司代码:600319 公司简称:ST 亚星 潍坊亚星化学股份有限公司 2021 年第一季度报告 1 / 24 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整, 不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人韩海滨、主管会计工作负责人伦秀华及会计机构负责人(会计主管人员)王钦志 保证季度报告中财务报表的真实、准确、完整。 本公司第一季度报告未经审计。 由于公司生产厂区于 2019 年 10 月 31 日全面关停,公司不再单独披露 2021 年第一季度报告主 要经营数据的临时公告。敬请投资者充分注意该因素对本报告中同比数据等的影响。 二、 公司基本情况 2.1 主要财务数据 | | 本报告期末 | 上年度末 | 本报告期末比上 年度末增减(%) | | --- | ...
亚星化学(600319) - 2020 Q3 - 季度财报
2020-10-23 16:00
Financial Performance - Operating revenue for the first nine months dropped by 96.95% to CNY 42,842,047.28 compared to the same period last year[6]. - Net profit attributable to shareholders was a loss of CNY 19,979,155.37, a decrease of 202.25% compared to the same period last year[6]. - The company's net loss for the first three quarters of 2020 was CNY 1,096,767,039.05, worsening from a loss of CNY 1,075,911,794.01 in the same period of 2019[27]. - The company reported a significant drop in operating revenue for Q3 2020, totaling CNY 4,096,705.62, down from CNY 445,689,240.04 in Q3 2019, a decrease of about 99.1%[28]. - The net loss for Q3 2020 was CNY 4,508,076.34, compared to a net loss of CNY 1,478,093.06 in Q3 2019, indicating a worsening financial performance[32]. - The total profit loss for the first three quarters of 2020 reached CNY 20,855,245.04, compared to a profit of CNY 19,442,770.82 in the same period of 2019[32]. Assets and Liabilities - Total assets increased by 21.70% to CNY 1,583,452,787.38 compared to the end of the previous year[6]. - Current assets decreased to CNY 254,872,000.72 from CNY 498,443,435.11, a decline of about 48.9%[23]. - Total liabilities rose to CNY 1,538,849,035.64 from CNY 1,236,548,793.69, an increase of approximately 24.5%[24]. - The company’s total equity decreased to CNY 44,603,751.74 from CNY 64,582,907.11, a decline of approximately 30.9%[24]. - The company reported a significant decrease in cash and cash equivalents, down 53.81% to ¥144,817,042.35 compared to the previous period[15]. - The company’s total liabilities included short-term borrowings of 838,265,722.88 RMB, reflecting the ongoing financing strategy amidst cash flow challenges[41]. Cash Flow - Net cash flow from operating activities for the first nine months was -CNY 70,270,474.18, a decrease of 157.28% compared to the same period last year[6]. - Cash flow from operating activities for the first three quarters of 2020 was negative at CNY -70,270,474.18, a decline from a positive cash flow of CNY 122,672,039.93 in the same period of 2019[33]. - The company incurred total cash outflows from operating activities of 167,954,570.26 RMB, a reduction of about 82% compared to 923,917,149.73 RMB in the previous year[37]. - The cash flow from financing activities showed a net outflow of -71,242,636.53 RMB, compared to -137,968,339.57 RMB in the previous year, representing an improvement of about 48%[38]. Shareholder Information - The total number of shareholders at the end of the reporting period was 12,690[9]. - The largest shareholder, Beijing Guangyao Dongfang Commercial Management Co., Ltd., held 12.67% of the shares[9]. Operational Changes - The company is currently in the process of relocating and rebuilding, with plans to complete a 50,000 tons/year CPE facility by the end of the year and a 120,000 tons/year caustic soda facility by early 2021[18]. - The company received government compensation of ¥600 million for relocation, with ¥440 million received in the current period[17]. - The company anticipates a potential net loss for the year due to ongoing production suspension during the relocation[19]. Inventory and Receivables - Accounts receivable decreased by 81.79% to ¥9,895,295.86, primarily due to reduced sales volume following production suspension[15]. - Inventory decreased by 34.65% to ¥60,086,436.60, attributed to the sale of finished products and raw materials during the production halt[15]. - The company reported a total of 91,940,446.20 RMB in inventory as of Q3 2020, remaining unchanged from the previous reporting period[41]. Research and Development - The company’s R&D expenses decreased by 66.20% to ¥1,207,039.02, reflecting reduced operational activities[15]. - Research and development expenses for Q3 2020 were CNY 350,354.57, down from CNY 1,253,543.07 in Q3 2019, reflecting a reduction in investment in innovation[31].